GMDA News and Press, Gamida Cell Ltd. From 02/09/22

Gamida Cell (NASDAQ:GMDA) began a rolling submission of its biologics license application (BLA) with the U.S. Food and Drug Administration for omidubicel, a treatment for patients with blood cancers in need of stem cell transplant.The company said it remains on track to complete the...

On track to complete the BLA submission in the first half of 2022 Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for cancer and other serious diseases, today announced that it has initiated the Biologics License Application (BLA) rolling...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for cancer and other serious diseases, today announced the addition of Anat Cohen-Dayag, Ph.D., and Naama Halevi-Davidov, Ph.D., to its Board of Directors as Class II Directors. “We are v...

Initiating rolling BLA submission for omidubicel in the first quarter of 2022 with full BLA submission on track for first half of 2022 Evaluating strategic alternatives for commercialization of omidubicel, including potential licensing or partnering Reducing operatin...

3 Penny Stocks That Are Popular With Investors Right Now If you’re looking for popular penny stocks to add to your watchlist, there are hundreds to choose from. While it can be difficult to pick the best penny stocks for your watchlist, doing so can mean the difference betwee...

Palm Beach, FL – January 20, 2022 – FinancialNewsMedia.com News Commentary – Despite significant progress in the treatment of gastric cancer, it is still among the leading causes of deaths due to cancer, across the world. The high mortality rates are pr...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Several penny stocks are on the move Wednesday and we’re diving into the hot news behind that momentum. Source: Shutterstock But before we get too far into this, remember that penny stocks can be incredibly v...

Small- and micro-cap companies take the cake when it comes to cheap stocks to buy. They’re well-known for their risk/reward profile, but they’re also known for their unique trends. Things like “low float stocks” or “ short squeeze stocks ” are m...

Planning to initiate rolling BLA submission for omidubicel following positive Type B meeting with FDA Full BLA submission on track for first half of 2022 Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for cancer and other s...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for cancer and other serious diseases, today announced eight presentations at the 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings (TCT) being held in Salt La...